Metabolic profiling using combined GC–MS and LC–MS provides a systems understanding of aristolochic acid‐induced nephrotoxicity in rat
暂无分享,去创建一个
Yan Ni | Wei Jia | Mingming Su | Yunping Qiu | Minjun Chen | Minjun Chen | W. Jia | M. Su | Y. Qiu | Yan Ni | A. Zhao | Yu-min Liu | Yuming Liu | Aihua Zhao | Yunping Qiu
[1] R. Lin,et al. Structure activity relationships of aristolochic acid analogues: toxicity in cultured renal epithelial cells. , 2005, Kidney international.
[2] I. Wilson,et al. A combined (1)H NMR and HPLC-MS-based metabonomic study of urine from obese (fa/fa) Zucker and normal Wistar-derived rats. , 2005, Journal of pharmaceutical and biomedical analysis.
[3] C. Zoccali. Biomarkers in chronic kidney disease: utility and issues towards better understanding , 2005, Current opinion in nephrology and hypertension.
[4] R. Kini,et al. Characterization of three edema-inducing phospholipase A2 enzymes from habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid. , 1987, Toxicon : official journal of the International Society on Toxinology.
[5] M. Rantalainen,et al. Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice. , 2006, Journal of proteome research.
[6] Jeremy K Nicholson,et al. Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity. , 2004, Chemical research in toxicology.
[7] M. Jadoul,et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs , 1993, The Lancet.
[8] K. Clarke,et al. A study of metabolic compartmentation in the rat heart and cardiac mitochondria using high‐resolution magic angle spinning 1H NMR spectroscopy , 2003, FEBS letters.
[9] L. Hood,et al. A data integration methodology for systems biology: experimental verification. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[10] Mark R Viant,et al. NMR-based metabolomics: a powerful approach for characterizing the effects of environmental stressors on organism health. , 2003, Environmental science & technology.
[11] D. Denson,et al. Contrasting effects of cPLA2 on epithelial Na+ transport. , 2001, American journal of physiology. Cell physiology.
[12] Leroy Hood,et al. The impact of systems approaches on biological problems in drug discovery , 2004, Nature Biotechnology.
[13] Jeremy K Nicholson,et al. NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. , 2003, Chemical research in toxicology.
[14] D. Gauguier,et al. Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. , 2005, Analytical chemistry.
[15] J C Lindon,et al. Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine. , 1991, Molecular pharmacology.
[16] A. Smilde,et al. Fusion of mass spectrometry-based metabolomics data. , 2005, Analytical chemistry.
[17] O. Fiehn,et al. Metabolite profiling for plant functional genomics , 2000, Nature Biotechnology.
[18] I. Wilson,et al. A multi-analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese rats. , 2006, Molecular bioSystems.
[19] E. Lock,et al. Sodium benzoate attenuates D-serine induced nephrotoxicity in the rat. , 2005, Toxicology.
[20] J. J. Moreno. Effect of aristolochic acid on arachidonic acid cascade and in vivo models of inflammation. , 1993, Immunopharmacology.
[21] J. Lindon,et al. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.
[22] V. Arlt,et al. Aristolochic acid nephropathy and the peritoneum: Functional, structural, and molecular studies. , 2003, Kidney international.
[23] M E Sullivan,et al. Use of cultured cells of kidney origin to assess specific cytotoxic effects of nephrotoxins. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.
[24] Hai-yan Wang,et al. Possible mechanisms explaining the tendency towards interstitial fibrosis in aristolochic acid-induced acute tubular necrosis. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[25] J. Lindon,et al. Pharmaco-metabonomic phenotyping and personalized drug treatment , 2006, Nature.
[26] V. Arlt,et al. Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells. , 2001, Kidney international.
[27] M. Tanner,et al. Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[28] L. Sarda,et al. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells , 1995, Cell.
[29] Galli Giovanni,et al. Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects? , 2002, Journal of nephrology.
[30] Y. Guiot,et al. Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? , 2001, Kidney international.
[31] B. Vishwanath,et al. Effects of aristolochic acid on phospholipase A2 activity and arachidonate metabolism of human neutrophils. , 1989, Biochimica et biophysica acta.
[32] Minjun Chen,et al. Application of ethyl chloroformate derivatization for gas chromatography-mass spectrometry based metabonomic profiling. , 2007, Analytica chimica acta.
[33] U. Mengs,et al. Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology , 2005, Archives of Toxicology.
[34] G. Deray,et al. Herbs and the kidney. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[35] J. Van Camp,et al. Creatine supplementation decreases homocysteine in an animal model of uremia. , 2003, Kidney international.
[36] M. Rantalainen,et al. The metabonomics of aging and development in the rat: an investigation into the effect of age on the profile of endogenous metabolites in the urine of male rats using 1H NMR and HPLC-TOF MS. , 2005, Molecular bioSystems.
[37] V. Buckalew,et al. Nephrolithiasis in renal tubular acidosis. , 1989, The Journal of urology.
[38] Ping Liu,et al. Metabonomic study of aristolochic acid-induced nephrotoxicity in rats. , 2006, Journal of proteome research.
[39] U. Mengs,et al. Acute toxicity of aristolochic acid in rodents , 1987, Archives of Toxicology.